| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Korro Bio, Inc. (KRRO) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. KRRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.54M | $21.34M | - | |
| 10% | 1.30M | $18.01M | - | |
| 10% | 1.30M | $18.01M | - | |
| 10% | 1.30M | $18.01M | - | |
| 10% | 1.30M | $18.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2020 | Lucchino David L.45 | President And CEO | Sell | 15,714 | $18.55 | $291,473.52 | -2.1% | |
| Aug 19, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $22.97 | $103,349.70 | -2.9% | |
| Aug 5, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $21.21 | $95,463.75 | -1.4% | |
| Aug 3, 2020 | Lucchino David L.45 | President And CEO | Sell | 15,714 | $21.63 | $339,829.39 | -3.9% | |
| Jul 22, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $21.51 | $96,790.50 | -2.7% | |
| Jul 20, 2020 | Marcus Joel S68 | Director | Buy | 55,555 | $18.00 | $999,990.00 | +5.8% | |
| Jul 8, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $22.32 | $100,439.07 | -1.3% | |
| Jul 1, 2020 | Lucchino David L.45 | President And CEO | Sell | 15,714 | $22.45 | $352,832.73 | -3.8% | |
| Jun 24, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $22.80 | $102,586.95 | -2.6% | |
| Jun 10, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $19.96 | $89,829.00 | -2.5% |